Shield Therapeutics PLC banner

Shield Therapeutics PLC
SWB:1JS

Watchlist Manager
Shield Therapeutics PLC Logo
Shield Therapeutics PLC
SWB:1JS
Watchlist
Price: 0.0905 EUR -8.12%
Market Cap: €254.2m

Wall St Price Targets

1JS Price Targets Summary
Shield Therapeutics PLC

Wall Street analysts forecast 1JS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1JS is 0.3576 EUR with a low forecast of 0.255 EUR and a high forecast of 0.508 EUR.

Lowest Forecast
Price Target
0.255 EUR
182% Upside
Average Forecast
Price Target
0.3576 EUR
295% Upside
Highest Forecast
Price Target
0.508 EUR
461% Upside
Shield Therapeutics PLC Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss
N/A
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss

The compound annual growth rate for Revenue over the next 6 years is 28%.

Gross Profit
Forecast

N/A
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss
N/A
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss

The compound annual growth rate for Gross Profit over the next 6 years is 32%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1JS's stock price target?
Price Target
0.3576 EUR

According to Wall Street analysts, the average 1-year price target for 1JS is 0.3576 EUR with a low forecast of 0.255 EUR and a high forecast of 0.508 EUR.

What is the Revenue forecast for Shield Therapeutics PLC?
Projected CAGR
28%

The compound annual growth rate for Revenue over the next 6 years is 28%.

What is the Gross Profit forecast for Shield Therapeutics PLC?
Projected CAGR
32%

The compound annual growth rate for Gross Profit over the next 6 years is 32%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett